These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 28885772)

  • 1. Overt hepatic encephalopathy impairs learning on the EncephalApp stroop which is reversible after liver transplantation.
    Acharya C; Wade JB; Fagan A; White M; Gavis E; Ganapathy D; Gilles H; Heuman DM; Bajaj JS
    Liver Transpl; 2017 Nov; 23(11):1396-1403. PubMed ID: 28885772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of EncephalApp, Smartphone-Based Stroop Test, for the Diagnosis of Covert Hepatic Encephalopathy.
    Bajaj JS; Heuman DM; Sterling RK; Sanyal AJ; Siddiqui M; Matherly S; Luketic V; Stravitz RT; Fuchs M; Thacker LR; Gilles H; White MB; Unser A; Hovermale J; Gavis E; Noble NA; Wade JB
    Clin Gastroenterol Hepatol; 2015 Oct; 13(10):1828-1835.e1. PubMed ID: 24846278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Stroop smartphone application is a short and valid method to screen for minimal hepatic encephalopathy.
    Bajaj JS; Thacker LR; Heuman DM; Fuchs M; Sterling RK; Sanyal AJ; Puri P; Siddiqui MS; Stravitz RT; Bouneva I; Luketic V; Noble N; White MB; Monteith P; Unser A; Wade JB
    Hepatology; 2013 Sep; 58(3):1122-32. PubMed ID: 23389962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive impairment and electroencephalographic alterations before and after liver transplantation: what is reversible?
    Campagna F; Montagnese S; Schiff S; Biancardi A; Mapelli D; Angeli P; Poci C; Cillo U; Merkel C; Gatta A; Amodio P
    Liver Transpl; 2014 Aug; 20(8):977-86. PubMed ID: 24809329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of Minimal Hepatic Encephalopathy Using Stroop EncephalApp: A Multicenter US-Based, Norm-Based Study.
    Allampati S; Duarte-Rojo A; Thacker LR; Patidar KR; White MB; Klair JS; John B; Heuman DM; Wade JB; Flud C; O'Shea R; Gavis EA; Unser AB; Bajaj JS
    Am J Gastroenterol; 2016 Jan; 111(1):78-86. PubMed ID: 26644276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of EncephalApp_Stroop as screening tool for the detection of minimal hepatic encephalopathy in German patients with liver cirrhosis.
    Kaps L; Hildebrand K; Nagel M; Michel M; Kremer WM; Hilscher M; Galle PR; Schattenberg JM; Wörns MA; Labenz C
    Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101873. PubMed ID: 35124289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy.
    Umapathy S; Dhiman RK; Grover S; Duseja A; Chawla YK
    Am J Gastroenterol; 2014 Jul; 109(7):1011-9. PubMed ID: 24777152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QuickStroop Predicts Time to Development of Overt Hepatic Encephalopathy and Related Hospitalizations in Patients With Cirrhosis.
    Kanagalingam G; Park D; Badal BD; Fagan A; Thacker LR; Bajaj JS
    Clin Gastroenterol Hepatol; 2024 Apr; 22(4):899-901.e2. PubMed ID: 37797903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy.
    Bajaj JS; Schubert CM; Heuman DM; Wade JB; Gibson DP; Topaz A; Saeian K; Hafeezullah M; Bell DE; Sterling RK; Stravitz RT; Luketic V; White MB; Sanyal AJ
    Gastroenterology; 2010 Jun; 138(7):2332-40. PubMed ID: 20178797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QuickStroop, a Shortened Version of EncephalApp, Detects Covert Hepatic Encephalopathy With Similar Accuracy Within One Minute.
    Acharya C; Shaw J; Duong N; Fagan A; McGeorge S; Wade JB; Thacker LR; Bajaj JS
    Clin Gastroenterol Hepatol; 2023 Jan; 21(1):136-142. PubMed ID: 34998992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal Hepatic Encephalopathy and Mild Cognitive Impairment Worsen Quality of Life in Elderly Patients With Cirrhosis.
    Bajaj JS; Duarte-Rojo A; Xie JJ; Acharya C; Wade JB; Robles C; Thacker LR; Flud C; Fagan A; Garcia-Saenz-de-Sicilia M; White MB; Kelly M; Nguyen V; Gavis EA; Vargas HE
    Clin Gastroenterol Hepatol; 2020 Dec; 18(13):3008-3016.e2. PubMed ID: 32205222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome Prediction of Covert Hepatic Encephalopathy in Liver Cirrhosis: Comparison of Four Testing Strategies.
    Labenz C; Toenges G; Schattenberg JM; Nagel M; Huber Y; Marquardt JU; Labenz J; Galle PR; Wörns MA
    Clin Transl Gastroenterol; 2020 Jun; 11(6):e00172. PubMed ID: 32568474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EncephalApp Stroop App predicts poor sleep quality in patients with minimal hepatic encephalopathy due to hepatitis B-induced liver cirrhosis.
    Luo M; Yu XB; Hu SJ; Bai FH
    Saudi J Gastroenterol; 2020; 26(3):120-128. PubMed ID: 32270775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The Psychometric Score for Hepatic Encephalopathy and the Stroop EncephalApp in the diagnosis of covert hepatic encephalopathy in Cuba].
    Padilla Ruiz MA
    Rev Gastroenterol Peru; 2021; 41(1):21-26. PubMed ID: 34347766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of EncephalApp Stroop Test in Cirrhotic Patients for Evaluating Covert Hepatic Encephalopathy.
    Kurniawan J; Ranty SS; Sulaiman AS; Gani RA
    Acta Med Indones; 2023 Jul; 55(3):296-306. PubMed ID: 37915156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EncephalApp Stroop Test for covert hepatic encephalopathy screening in Tunisian cirrhotic patients.
    Hamzaoui L; Mahmoudi M; Mohamed G; Elloumi H; Laabidi A; Boubaker J; Boudabbous M; Tahri N; Jemni I; Safer L; Jomni T; Douggui H; Trad D; Gargouri D; Ayadi S; Debbeche R; Belhouchet S; Marouani R; Cheikh I; Abdelli MN
    F1000Res; 2022; 11():686. PubMed ID: 37767072
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnosis of covert hepatic encephalopathy: a multi-center study testing the utility of single versus combined testing.
    Duarte-Rojo A; Allampati S; Thacker LR; Flud CR; Patidar KR; White MB; Klair JS; Heuman DM; Wade JB; Gavis EA; Bajaj JS
    Metab Brain Dis; 2019 Feb; 34(1):289-295. PubMed ID: 30506333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of overt hepatic encephalopathy by the continuous reaction time method and the portosystemic encephalopathy syndrome test in clinically mentally unimpaired patients with cirrhosis.
    Wernberg CW; Schaffalitzky de Muckadell OB; Vilstrup H; M Lauridsen M
    PLoS One; 2019; 14(12):e0226283. PubMed ID: 31830113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant topological organization of the functional brain network associated with prior overt hepatic encephalopathy in cirrhotic patients.
    Chen HJ; Chen QF; Yang ZT; Shi HB
    Brain Imaging Behav; 2019 Jun; 13(3):771-780. PubMed ID: 29846883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis.
    Ballester MP; Tranah TH; Balcar L; Fiorillo A; Ampuero J; Kerbert AJC; Thomsen KL; Escudero MD; Mandorfer M; Reiberger T; Shawcross DL; Romero-Gómez M; Montoliu C; Carbonell-Asins JA; Jalan R
    J Hepatol; 2023 Oct; 79(4):967-976. PubMed ID: 37277075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.